Global Antipsychotic Drugs Market is valued at USD 14.37 Billion in 2021 and expected to reach USD 22.89 Billion by 2028 with a CAGR of 6.87% over the forecast period
Increasing incidences of mental disorders, rising number of product launches of antipsychotic drugs, and growing geriatric populations are major factors anticipated to drive the growth of Global Antipsychotic Drugs Market.
Download Free Exclusive Sample (200 Pages PDF) Report @ :
Scope of Global Antipsychotic Drugs Market Report: –
Antipsychotics drugs are drugs that are used to treat symptoms of psychosis-like delusions, confused thoughts, hallucinations, paranoia. Severe anxiety, schizophrenia, and severe anxiety can be treated with antipsychotic drugs. Antipsychotics also are useful at stabilizing episodes of mania in people with manic depression. Disorganized thinking, trouble in concentrating and memory problems can be controlled by antipsychotics. Antipsychotic medications are generally divided into two types atypical (second generation) antipsychotics and typical (first generation) antipsychotics. Antipsychotic drugs are used to treat people with psychosis that occurs in bipolar disorder, depression and Alzheimer’s disease. Bipolar disorders, anxiety, reducing anxiety in anxiety disorders and reducing tics in Tourette syndrome also some of the uses of antipsychotic drugs.
Key Players for Global Antipsychotic Drugs Market Report: –
- Dr. Reddy’s Laboratories
- GlaxoSmithKline plc
- Eli Lily Company
- Johnson & Johnson
- AstraZeneca plc
- Teva Pharmaceuticals
- Otsuka Pharmaceutical Co, Ltd.
- Bristol-Myers Squibb
- Pfizer Inc.
- AbbVie Inc.
Global Antipsychotic Drugs Market Segmentation: –
By Disease Type:
- Bipolar Disorder
- Unipolar Depression
By Distribution Channel:
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- Veterinary Hospitals
- Hog Production Farm
Get Methodology of the Antipsychotic Drugs Market Report @:
News- Intra-Cellular Therapies Announced U.S. FDA Approval of CAPLYTA (lumateperone) for the Treatment of Bipolar Depression in Adults
On December 20th, 2021; U.S Food and Drug Administration approved Intra-Cellular Therapies, Inc. a biopharmaceutical company focusing on the development and commercialization of therapeutics for central nervous system (CNS) disorders, approved CAPLYTA for the treatment of depressive episodes associated with bipolar I or II disorder in adults, as monotherapy and as adjunctive therapy with lithium or valproate. CAPLYTA is that the only medication approved by the FDA to treat depressive disorders related to bipolar I or bipolar II as both monotherapy and adjunctive therapy with lithium or valproate. CAPLYTA has shown a uniform favorable profile on weight, cardiometabolic parameters and extrapyramidal symptoms.
Alkermes Announced FDA Approval of LYBALVI for the Treatment of Schizophrenia and Bipolar I Disorder
On June 1st, 2021; U.S Food and Drug Administration announced approval of Alkermes plc. LYBALVI (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder. LYBALVI is composed of olanzapine prescribed as once-daily. LYBALVI proved antipsychotic efficacy, safety and tolerability, including statistically significantly less weight gain than olanzapine in patients with schizophrenia in the ENLIGHTEN-2 study. LYBALVI is co-formulated with samidorphan, in a single bilayer tablet. 10 mg of samidorphan and 5mg, 10mg, 15mg or 20mg of olanzapine doses are available for the LYBALVI tablet.
North America Expected to Dominate the Global Antipsychotic Drugs Market
North America is expected to dominate the global antipsychotic drugs market due to rising prevalence of schizophrenia, high awareness regarding mental health and growing adoption of antipsychotic drugs. For instance; according to the Schizophrenia and Related Disorders Alliance of America; 3.5 million Americans have been diagnosed with schizophrenia in 2020. Thus, the rising prevalence and increasing incidence of schizophrenia is boosting the growth of the anti-psychotic drugs market. In addition to that, high awareness about the mental health in North America is augmenting the growth of the market as the different strategies and prevention techniques were carried for promoting mental health awareness. Moreover, growing adoption of psychotic drugs is also boosting the market growth. For instance; on December 20th, 2021, Food and Drug Administration (FDA) approved Intra-Cellular Therapies CAPLYTA (lumateperone) for the treatment of bipolar depression in adults.
The Asia Pacific is expected to capture a significant share in the global antipsychotic drugs market due to the growing prevalence of mental disorders, rising awareness about mental health and launching of new antipsychotic drugs. For example; 38 million people had depression in 2020 according to World Health Organization. These increasing number of mental disorders will increase the growth of the antipsychotic drugs for the need of treatment. In addition, rising awareness about psychotic disorders by government and social media influencers are also adding the growth to the market.
On Special Requirement Antipsychotic Drugs Market Report is also available for below Regions and Country:
- Rest of Europe
- South Korea
- Rest Of APAC
- Rest of South America
Middle East and Africa
- Saudi Arabia
- South Africa
- Rest Of MEA
Buy Now @
This comprehensive report will provide:
- Enhance your strategic decision making
- Assist with your research, presentations, and business plans
- Show which emerging market opportunities to focus on
- Increase your industry knowledge
- Keep you up-to-date with crucial market developments
- Allow you to develop informed growth strategies
- Build your technical insight
- Illustrate trends to exploit
- Strengthen your analysis of competitors
- Provide risk analysis, helping you avoid the pitfalls other companies could make
- Ultimately, help you to maximize profitability for your company.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of the market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are the main factors responsible for new product launches?
- How big are the global & regional markets in terms of revenue, sales, and production?
- How far will the market grow in the forecast period in terms of revenue, sales, and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2028?
- Which region has more opportunities?
Key Benefits in Global Antipsychotic Drugs Market Report-
- Global Antipsychotic Drugs Market report covers in-depth historical and forecast analysis.
- Global Antipsychotic Drugs Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, and Regional and Country levels.
- Global Antipsychotic Drugs Market report helps to identify opportunities in the marketplace.
- Global Antipsychotic Drugs Market report covers extensive analysis of emerging trends and the competitive landscape.
Get Access to the Full Report Here:
The Global Surgical Instrument Tracking Systems Market in terms of revenue was worth of USD 193.8 Million in 2021 and is Projected to reach USD 513.1 Million by 2028, growing at a CAGR of 14.92% from 2021 to 2027.
Animal Vaccine Market was worth of USD 11.13 billion in 2021 and it is expected to reach 20.48 billion by the end of 2028 with the CAGR of 9.1% during Forecast Period.
Hemophilia Gene Therapy Market is valued at USD 331.4 Million in 2021 and expected to reach USD 4092.6 Million by 2028 with a CAGR of 43.2% over the forecast period.
Global Bioinformatics Market in terms of revenue was worth of USD 10.82 Billion in 2021 and expected to reach USD 24.07 Billion by 2028, growing at a CAGR of 12.1% from 2021 to 2028.
Colorectal Cancer Market is valued at USD 11.83 Billion in 2021 and is expected to reach USD 16.21 Billion by 2028 with a CAGR of 5.40% over the forecast period.
Global Medical Tricorder Market is valued at USD 3425.4 Million in 2021 and is expected to reach USD 5411.2 Million by 2028 with a CAGR of 6.75% over the forecast period.
Global Healthcare CRM Market is valued at USD 12.53 Billion in 2021 and is expected to reach USD 31.54 Billion by 2028 with a CAGR of 14.1% over the forecast period.
The Global Metaverse in Healthcare Market is valued at USD 5056.4 Million in 2021 and is expected to reach USD 7453.6 Million by 2028 with a CAGR of 33.7% over the forecast period.
Global Demand For Advanced Wound Care Market, in terms of revenue, was estimated to be USD 9.01 billion in 2018 and is expected to reach USD 13.27 billion in 2025, growing at a CAGR of 5.85% from 2019 to 2025.
According to Brandessence Market Research latest research study says Global demand for biophotonics market size in terms of revenue, was worth of USD 53.28 Billion in 2020. The biophotonics market is likely to reach USD 109.23 Billion by 2027 end, growing at a robust 10.8% CAGR.
The Global Sterility Testing Market in terms of revenue was worth of USD 1036.13 Million in 2021 and expected to reach USD 2193.8 Million by 2028, growing at a CAGR of 12.6% from 2021 to 2028.
i-Factor: Live Market intelligence platform
I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trial here at https://brandessenceresearch.com/i-factor/login/userRegister
Brandessence Market Research & Consulting Pvt ltd.
Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Mr. Vishal Sawant
Corporate Sales: +44-2038074155
Asia Office: +917447409162